The Weekly Litigation News Digest is now live. Subscribe now

IP Verse

Ceva Sant Animale competitive analysis

Loading summary...

Latest patents of Ceva Sant Animale opposed by its competitors

Explore Ceva Sant Animale's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 13, 2025
Patent NumberPublication DateTitleTotal Oppositions
EP2831246
Nov 6, 2024Multivalent Recombinant Avian Herpes Viruses And Vaccines For Immunizing Avian Species1
EP3148576
Dec 30, 2020Vaccine Composition Against Streptococcus Suis Infection1
EP3566695
Aug 5, 2020Treatment Of Coccidiosis With Intramuscular Triazine Compositions2
EP2928454
Mar 18, 2020New Treatments With Triazines2
EP2928455
Aug 21, 2019Treatment Of Coccidiosis With Intramuscular Triazine Compositions2
EP3041939
Mar 27, 2019Recombinant Marek'S Disease Viruses And Uses Thereof1
EP2598151
Dec 26, 2018Compositions For Treating Heartworm Infestation1
EP2750704
Oct 4, 2017Synthetic Capsid Proteins And Uses Thereof1

Latest PTAB cases involving Ceva Sant Animale

Discover the latest PTAB cases involving Ceva Sant Animale, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Ceva Sant Animale with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 13, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
CEVA SANT ANIMALE - 11 - -
BAYER ANIMAL HEALTH33 - -
BOEHRINGER INGELHEIM ANIMAL HEALTH USA16302 -
ELANCO11 - - 1